These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15821836)

  • 1. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
    Bonetti PO; Kaiser C; Zellweger MJ; Grize L; Erne P; Schoenenberger RA; Pfisterer ME;
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):29-37. PubMed ID: 15821836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME).
    Pfisterer M;
    Circulation; 2004 Sep; 110(10):1213-8. PubMed ID: 15337691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.
    Pfisterer M; Buser P; Osswald S; Allemann U; Amann W; Angehrn W; Eeckhout E; Erne P; Estlinbaum W; Kuster G; Moccetti T; Naegeli B; Rickenbacher P;
    JAMA; 2003 Mar; 289(9):1117-23. PubMed ID: 12622581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectoris.
    Jeger RV; Bonetti PO; Zellweger MJ; Tobler D; Kaiser CA; Osswald S; Buser PT; Pfisterer ME
    Am J Cardiol; 2005 Jul; 96(2):193-8. PubMed ID: 16018840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.
    Allen KB; Dowling RD; Fudge TL; Schoettle GP; Selinger SL; Gangahar DM; Angell WW; Petracek MR; Shaar CJ; O'Neill WW
    N Engl J Med; 1999 Sep; 341(14):1029-36. PubMed ID: 10502592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial.
    Kaiser C; Kuster GM; Erne P; Amann W; Naegeli B; Osswald S; Buser P; Schläpfer H; Brett W; Zerkowski HR; Schindler C; Pfisterer M;
    Eur Heart J; 2004 Jun; 25(12):1036-42. PubMed ID: 15191774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.
    TIME Investigators
    Lancet; 2001 Sep; 358(9286):951-7. PubMed ID: 11583747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.
    Lancet; 1997 Aug; 350(9076):461-8. PubMed ID: 9274581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.
    Frazier OH; March RJ; Horvath KA
    N Engl J Med; 1999 Sep; 341(14):1021-8. PubMed ID: 10502591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection bias of elderly patients with chronic angina referred for catheterization.
    Kaiser C; Jeger R; Wyrsch S; Schoeb L; Kuster GM; Buser P; Osswald S; Bernet F; Brett W; Grize L; Pfisterer M;
    Int J Cardiol; 2006 Jun; 110(1):80-5. PubMed ID: 16225942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation.
    Pettersson T; Bondesson S; Cojocaru D; Ohlsson O; Wackenfors A; Edvinsson L
    BMC Cardiovasc Disord; 2006 Jun; 6():28. PubMed ID: 16776842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
    Claude J; Schindler C; Kuster GM; Schwenkglenks M; Szucs T; Buser P; Osswald S; Kaiser C; Grädel C; Estlinbaum W; Rickenbacher P; Pfisterer M;
    Eur Heart J; 2004 Dec; 25(24):2195-203. PubMed ID: 15589636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina.
    Loh PH; Louis AA; Windram J; Rigby AS; Cook J; Hurren S; Nikolay NP; Caplin J; Cleland JG
    J Intern Med; 2006 Mar; 259(3):276-84. PubMed ID: 16476105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
    Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
    Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
    Koren MJ; Crager MR; Sweeney M
    J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
    Kumar S; Hall RJ
    Drugs Aging; 2003; 20(11):805-15. PubMed ID: 12964887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
    Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
    J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.